Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Signal Transduct Target Ther ; 8(1): 345, 2023 09 13.
Artículo en Inglés | MEDLINE | ID: mdl-37699892

RESUMEN

Amino acids are the building blocks of protein synthesis. They are structural elements and energy sources of cells necessary for normal cell growth, differentiation and function. Amino acid metabolism disorders have been linked with a number of pathological conditions, including metabolic diseases, cardiovascular diseases, immune diseases, and cancer. In the case of tumors, alterations in amino acid metabolism can be used not only as clinical indicators of cancer progression but also as therapeutic strategies. Since the growth and development of tumors depend on the intake of foreign amino acids, more and more studies have targeted the metabolism of tumor-related amino acids to selectively kill tumor cells. Furthermore, immune-related studies have confirmed that amino acid metabolism regulates the function of effector T cells and regulatory T cells, affecting the function of immune cells. Therefore, studying amino acid metabolism associated with disease and identifying targets in amino acid metabolic pathways may be helpful for disease treatment. This article mainly focuses on the research of amino acid metabolism in tumor-oriented diseases, and reviews the research and clinical research progress of metabolic diseases, cardiovascular diseases and immune-related diseases related to amino acid metabolism, in order to provide theoretical basis for targeted therapy of amino acid metabolism.


Asunto(s)
Enfermedades Cardiovasculares , Humanos , Enfermedades Cardiovasculares/genética , Aminoácidos , Ciclo Celular , Diferenciación Celular , Proliferación Celular
2.
Zhonghua Yan Ke Za Zhi ; 47(6): 527-30, 2011 Jun.
Artículo en Zh | MEDLINE | ID: mdl-21914268

RESUMEN

OBJECTIVE: To assess the safety and efficiency of posterior scleral reinforcement surgery by analyzing data collected for more than ten years after the surgery. METHODS: Sixteen patients (32 eyes) with high myopia who underwent scleral reinforcement were followed up for more than ten years (10 to 13 years). RESULTS: Best corrected visual acuity was stable (t = 0.26, P > 0.05). The average axial elongation was 0.056 mm per year postoperation after surgery. The ratio of choroidal neovascularization in the operation group was 3.1% (1/32). CONCLUSIONS: Posterior scleral reinforcement is a safe and effective. This procedure can prevent the development of choroidal neovascularization in high myopia. A control study with a larger group of cases as well as related basic is still required.


Asunto(s)
Miopía/cirugía , Procedimientos Quirúrgicos Oftalmológicos/métodos , Esclerótica/cirugía , Adolescente , Adulto , Niño , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA